SB-480848

structure in first source

Also Known As:

480848

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Rotella, David P: 1 article (03/2004)

1.	Atherosclerosis 03/01/2004 - "SB-480848 is a reversible lipoprotein-associated phospholipase A2 inhibitor under development by GlaxoSmithKline for the potential treatment of atherosclerosis. "

1.	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)